Search Results - "Durigon, N"

Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases by Cozzi, F., Montisci, R., Marotta, H., Bobbo, F., Durigon, N., Ruscazio, M., Sfriso, P., Iliceto, S., Todesco, S.

“…Background  Pulmonary arterial hypertension (PAH) is a life‐threatening and debilitating complication of several connective tissue diseases. We aimed to…”
Get full text

Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities by Cozzi, F., Chiesura Corona, M., Rizzi, M., Dus, C., Durigon, N., Mancin, S., Todesco, S.

“…OBJECTIVE: To define the prevalence of interstitial lung fibrosis in systemic sclerosis (SSc) and its relationship with the different clinical forms of disease…”
Get full text

Esophageal dysmotility in scleroderma patients with different disease forms and ANA patterns: a scintigraphic study in 100 cases by Cozzi, F., Zucchetta, P., Durigon, N., Marzola, M.C., Bullo, A., Favaro, M., Bui, F., Todesco, S.

“…Objective: To define the prevalence and severity of esophageal involvement in systemic sclerosis (SSc) and its relationship with the different clinical forms…”
Get full text

6 P Gastric dismotility in systemic sclerosys a preliminary study by real-time ultrasonography by Parisi, G., Bullo, A., Durigon, N., Tiso, F., Cozzi, F., Todesco, S.

Get full text

Changes in esophageal peristalsis in diverse clinical forms and antibody specificity in scleroderma: a scintigraphic study in 100 cases by Cozzi, F, Zucchetta, P, Durigon, N, Marzola, M C, Bullo, A, Favaro, M, Bui, F, Todesco, S

“…To define the prevalence and severity of esophageal involvement in systemic sclerosis (SSc) and its relationship with the different clinical forms and ANA…”
Get full text

Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities by Cozzi, F, Chiesura Corona, M, Rizzi, M, Dus, C, Durigon, N, Mancin, S, Todesco, S

Get full text